InsiderTrades.com logo

BCDA Insider Trading

Insider Ownership Percentage: 17.40%
Insider Buying (Last 12 Months): $1,430,735.13
Insider Selling (Last 12 Months): $6,514.00

BioCardia Insider Trading History Chart

This chart shows the insider buying and selling history at BioCardia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioCardia Share Price & Price History

Current Price: $1.47
Price Change: ▲ Price Increase of +0.05 (3.52%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for BCDA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BioCardia Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/19/2025Andrew Scott BlankDirectorBuy288,000$1.25$360,000.00634,023View SEC Filing Icon  
9/19/2025Peter AltmanCEOBuy48,000$1.25$60,000.00216,762View SEC Filing Icon  
9/19/2025Simon H StertzerDirectorBuy398,400$1.25$498,000.00591,054View SEC Filing Icon  
8/22/2025Peter AltmanCEOBuy700$1.83$1,281.00168,762View SEC Filing Icon  
8/13/2025Peter AltmanCEOBuy100$1.83$183.00168,062View SEC Filing Icon  
8/12/2025Peter AltmanCEOBuy400$1.75$700.00167,962View SEC Filing Icon  
8/11/2025Peter AltmanCEOBuy1,700$1.76$2,992.00167,562View SEC Filing Icon  
6/30/2025Andrew Scott BlankDirectorBuy72,289$2.08$150,361.12346,023View SEC Filing Icon  
6/30/2025David McclungCFOBuy4,819$2.08$10,023.5247,950View SEC Filing Icon  
6/30/2025Peter AltmanCEOBuy24,096$2.08$50,119.68165,862View SEC Filing Icon  
6/30/2025Simon H StertzerDirectorBuy72,289$2.08$150,361.12192,654View SEC Filing Icon  
5/30/2025Peter AltmanCEOBuy100$2.21$221.00141,766View SEC Filing Icon  
5/22/2025Peter AltmanCEOBuy700$1.89$1,323.00141,666View SEC Filing Icon  
5/20/2025Peter AltmanCEOBuy1,600$2.08$3,328.00140,966View SEC Filing Icon  
5/16/2025Peter AltmanCEOBuy300$2.43$729.00139,366View SEC Filing Icon  
5/14/2025Peter AltmanCEOBuy100$2.99$299.00139,066View SEC Filing Icon  
4/23/2025Bill FacteauDirectorBuy13,123$1.91$25,064.9313,123View SEC Filing Icon  
4/23/2025Peter AltmanCEOBuy26,246$1.91$50,129.86138,966View SEC Filing Icon  
4/15/2025Peter AltmanCEOBuy100$2.14$214.00112,720View SEC Filing Icon  
4/10/2025Peter AltmanCEOBuy300$1.99$597.00112,320View SEC Filing Icon  
4/7/2025Peter AltmanCEOBuy500$1.96$980.00112,020View SEC Filing Icon  
4/3/2025Peter AltmanCEOBuy1,200$2.24$2,688.00109,620View SEC Filing Icon  
3/5/2025Simon H StertzerDirectorBuy1,000$2.45$2,450.0057,138View SEC Filing Icon  
3/3/2025Peter AltmanCEOBuy500$2.11$1,055.00108,420View SEC Filing Icon  
3/3/2025Simon H StertzerDirectorBuy22,753$2.30$52,331.9040,602View SEC Filing Icon  
2/7/2025Peter AltmanCEOBuy600$2.48$1,488.00107,920View SEC Filing Icon  
1/29/2025Peter AltmanCEOBuy500$2.40$1,200.00107,081View SEC Filing Icon  
12/23/2024Peter AltmanCEOBuy1,000$2.06$2,060.00106,581View SEC Filing Icon  
12/20/2024Edward M GillisSVPSell3,257$2.00$6,514.008,968View SEC Filing Icon  
12/5/2024Peter AltmanCEOBuy250$2.22$555.00105,581View SEC Filing Icon  
11/15/2024Peter AltmanCEOBuy1,350$1.87$2,524.50105,331View SEC Filing Icon  
7/1/2024Peter AltmanCEOBuy300$3.05$915.0039,745View SEC Filing Icon  
6/28/2024Peter AltmanCEOBuy200$2.99$598.0039,445View SEC Filing Icon  
6/21/2024Peter AltmanCEOBuy500$3.29$1,645.0039,245View SEC Filing Icon  
6/14/2024Peter AltmanCEOBuy500$3.52$1,760.0038,745View SEC Filing Icon  
6/10/2024Peter AltmanCEOBuy1,000$3.36$3,360.0038,245View SEC Filing Icon  
4/19/2024Peter AltmanCEOBuy183$5.55$1,015.6537,246View SEC Filing Icon  
3/28/2024Peter AltmanCEOBuy33$5.85$193.0537,063View SEC Filing Icon  
2/13/2024Peter AltmanCEOBuy7,207$6.90$49,728.3037,029View SEC Filing Icon  
1/19/2024Phillip Md Et Al FrostMajor ShareholderSell8,653$6.45$55,811.85126,401View SEC Filing Icon  
5/26/2023Peter AltmanCEOBuy413$24.00$9,912.0031,282View SEC Filing Icon  
1/11/2023Peter AltmanCEOBuy6$28.05$168.3023,581View SEC Filing Icon  
12/16/2022Phillip Md Et Al FrostMajor ShareholderBuy39,682$25.20$999,986.40135,055View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioCardia (NASDAQ:BCDA)

20.57% of BioCardia stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCDA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioCardia Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/8/2025Cetera Investment Advisers20,275$40K0.0%N/A0.369%Search for SEC Filing on Google Icon
5/9/2025CM Management LLC75,000$0.19M0.2%+200.0%1.472%Search for SEC Filing on Google Icon
4/30/2025Brown Advisory Inc.35,538$90K0.0%N/A0.759%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC30,987$68K0.0%+110.3%0.677%Search for SEC Filing on Google Icon
2/7/2025CM Management LLC25,000$54K0.0%N/A0.546%Search for SEC Filing on Google Icon
11/7/2023CM Management LLC600,000$0.26M0.3%+74.9%2.775%Search for SEC Filing on Google Icon
8/4/2023CM Management LLC343,000$0.92M0.9%+4.3%1.677%Search for SEC Filing on Google Icon
7/24/2023Vontobel Holding Ltd.30,751$82K0.0%+93.5%0.150%Search for SEC Filing on Google Icon
5/15/2023AIGH Capital Management LLC509,151$0.99M0.4%-14.5%2.523%Search for SEC Filing on Google Icon
4/12/2023Vontobel Holding Ltd.15,895$31K0.0%N/A0.079%Search for SEC Filing on Google Icon
2/16/2023AIGH Capital Management LLC595,237$1.24M0.4%N/A2.969%Search for SEC Filing on Google Icon
11/15/2022Family Management Corp142,186$0.28M0.1%N/A0.797%Search for SEC Filing on Google Icon
5/4/2022Commonwealth Equity Services LLC49,978$0.10M0.0%+18.1%0.296%Search for SEC Filing on Google Icon
1/31/2022Commonwealth Equity Services LLC42,307$82K0.0%+156.5%0.251%Search for SEC Filing on Google Icon
11/5/2021Advisor Group Holdings Inc.39,257$0.12M0.0%-8.4%0.233%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC16,492$51K0.0%N/A0.098%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioCardia logo
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. The company is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, it offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths. The company has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. BioCardia, Inc. is based in Sunnyvale, California.
Read More on BioCardia

Today's Range

Now: $1.47
Low: $1.40
High: $1.49

50 Day Range

MA: $1.37
Low: $1.22
High: $1.56

52 Week Range

Now: $1.47
Low: $1.00
High: $3.20

Volume

108,130 shs

Average Volume

60,355 shs

Market Capitalization

$15.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.67

Who are the company insiders with the largest holdings of BioCardia?

BioCardia's top insider investors include:
  1. Andrew Scott Blank (Director)
  2. Simon H Stertzer (Director)
  3. Peter Altman (CEO)
  4. Phillip Md Et Al Frost (Major Shareholder)
  5. David Mcclung (CFO)
  6. Bill Facteau (Director)
  7. Edward M Gillis (SVP)
Learn More about top insider investors at BioCardia.